Cellectar Biosciences (CLRB) Earnings Date, Estimates & Call Transcripts $0.28 -0.01 (-3.54%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cellectar Biosciences Earnings Summary Upcoming Q4 Earnings DateMay. 13Before Market OpensEstimatedActual EPS (Oct. 29) -$0.51 Missed By -$0.51 Cellectar Biosciences announced Q3 2024 earnings on October 29, 2024, reporting an EPS of -$0.51. With a trailing EPS of -$1.33, Cellectar Biosciences' earnings are expected to grow next year, from ($1.59) to ($0.72) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)CLRB Upcoming EarningsCellectar Biosciences' Q1 2025 earnings is scheduled for Tuesday, May 13, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q1 2025 Earnings ReportPowered by Get Cellectar Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cellectar Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLRB Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Remove Ads Cellectar Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.18-$0.18-$0.18Q2 20251-$0.16-$0.16-$0.16Q3 20251-$0.16-$0.16-$0.16Q4 20251-$0.16-$0.16-$0.16FY 20254($0.66)($0.66)($0.66) Remove Ads Cellectar Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------10/29/2024Q3 2024--$0.51 -$0.51-$0.84--5/14/2024Q1 2024-$0.50-$0.40+$0.10-$0.06--3/27/2024Q4 2023-$0.59-$0.66 -$0.07-$0.92--11/13/2023Q3 2023-$0.44-$0.82 -$0.38-$0.43--8/14/2023Q2 2023-$0.69-$0.73 -$0.04-$0.73--5/4/2023Q1 2023-$0.75-$0.76 -$0.01-$0.76-- Cellectar Biosciences Earnings - Frequently Asked Questions When is Cellectar Biosciences's earnings date? Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on CLRB's earnings history. How can I listen to Cellectar Biosciences's earnings conference call? The conference call for Cellectar Biosciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Cellectar Biosciences's conference call transcript? The conference call transcript for Cellectar Biosciences's latest earnings report can be read online. Read Transcript How much profit does Cellectar Biosciences generate each year? Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$42.77 million. CLRB has generated -$1.33 earnings per share over the last four quarters. What is Cellectar Biosciences's EPS forecast for next year? Cellectar Biosciences's earnings are expected to grow from ($1.59) per share to ($0.72) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kronos Bio Earnings Date Gain Therapeutics Earnings Date Oncolytics Biotech Earnings Date Verrica Pharmaceuticals Earnings Date VolitionRx Earnings Date PMV Pharmaceuticals Earnings Date ImmuCell Earnings Date Sutro Biopharma Earnings Date PDS Biotechnology Earnings Date Cue Biopharma Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s Next Remove Ads This page (NASDAQ:CLRB) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLRB Stock Free CLRB Stock Alerts